During the past decade, NYU Langone Nassau Gastroenterology Associates conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 14 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 7 clinical trials were completed. i.e. 350% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NYU Langone Nassau Gastroenterology Associates" #1 sponsor was "Pfizer" with 8 trials, followed by "Shire" with 3 trials sponsored, "Eli Lilly and Company" with 2 trials sponsored, "Celgene" with 1 trials sponsored and "Janssen Research & Development, LLC" with 1 trials sponsored. Other sponsors include -5 different institutions and companies that sponsored additional 5 trials in total.

According to Clinical.Site data, the most researched conditions in "NYU Langone Nassau Gastroenterology Associates" are "Crohn's Disease" (6 trials), "Ulcerative Colitis" (6 trials), "Crohn Disease" (2 trials) and "Colitis, Ulcerative" (1 trials). Many other conditions were trialed in "NYU Langone Nassau Gastroenterology Associates" in a lesser frequency.

Most popular intervention types in "NYU Langone Nassau Gastroenterology Associates" are "Drug" (15 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (9 trials), "CP-690,550" (5 trials), "Mirikizumab" (2 trials), "CP-690,500 5 mg" (1 trials) and "CP-690,550 10 mg" (1 trials). Other intervention names were less common.

The vast majority of trials in "NYU Langone Nassau Gastroenterology Associates" are 15 trials for "All" genders.

Currently, there are NaN active trials in "NYU Langone Nassau Gastroenterology Associates". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in NYU Langone Nassau Gastroenterology Associates, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in NYU Langone Nassau Gastroenterology Associates, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".